Jamestown, NC, United States of America

Ananthapadmanabhan Sivaramakrishnan

This inventor holds 2 USPTO granted patents. Top assignee: University of Pittsburgh. Active years: 2010-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ananthapadmanabhan Sivaramakrishnan. Retrieved from https://idiyas.com/inventor/ananthapadmanabhan-sivaramakrishnan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ananthapadmanabhan Sivaramakrishnan

Introduction

Ananthapadmanabhan Sivaramakrishnan is a notable inventor based in Jamestown, NC (US). He has made significant contributions to the field of cancer research through his innovative work. With a total of 2 patents, his inventions focus on the synthesis of compounds with potential antitumor activity.

Latest Patents

Sivaramakrishnan's latest patents include the synthesis of FR901464 and its analogs, which exhibit antitumor activity. The present invention provides novel analogs of FR901464, as well as an improved methodology for preparing these compounds. These compounds display anti-cancer activity and are candidates for therapies against various disease states associated with dysfunctional RNA splicing.

Career Highlights

He is currently affiliated with the University of Pittsburgh, where he continues to advance his research in the field of cancer therapeutics. His work has garnered attention for its potential impact on treatment options for patients suffering from cancer.

Collaborations

Some of his notable coworkers include Brian J Albert and Kazunori Koide, who have collaborated with him on various research projects.

Conclusion

Ananthapadmanabhan Sivaramakrishnan's innovative contributions to cancer research through his patents highlight the importance of continued research in developing effective therapies. His work exemplifies the potential of scientific innovation to address critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…